Prime Medicine Inc.
PRME | NASDAQ
$3.19
+$0.07 (+2.24%)
At close: Sep 21, 2026, 4:00 PM ET
$3.22
+$0.03 (+0.94%)
After-hours:
Sep 21, 2026, 7:56 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.07M | 4.03M | 4.63M | 5.98M | 4.96M | 3.85M | 2.98M | 800K | 591K | 591K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 45.85M | 47.71M | 45.85M | 45.85M | 1.86M | n/a | 1.32M | 1.32M | 1.32M | 1.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.16M | 5.73M | 6.99M | 6.99M | 5.83M |
Gross Profit | -41.77M | -43.68M | -41.22M | -39.88M | 3.1M | 3.85M | 1.67M | -515K | -724K | -724K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.16M | -5.73M | -6.99M | -6.99M | -5.83M |
Operating Income | -196.52M | -206.61M | -208.35M | -203.96M | -204.22M | -206.52M | -202.47M | -226.29M | -223.52M | -213.1M | -204.79M | -175.44M | -155.63M | -136.68M | -116.54M | -137.93M | -116.71M | -98.42M | -84.47M | -27M | -16.57M | -8.55M |
Interest Income | 4.49M | 4.98M | 4.68M | 5.13M | 4.69M | 4.03M | 3.52M | 1.98M | 1.7M | 1.72M | 1.05M | 1.05M | 635K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -187.89M | -198.37M | -201.14M | -197.34M | -199.28M | -202.15M | -195.88M | -219.25M | -217.55M | -204.44M | -198.41M | -172.24M | -150.56M | -138M | -122.77M | -144.83M | -134.47M | -102.95M | -165.85M | -105.02M | -86.24M | -87.97M |
Net Income | -187.89M | -198.37M | -201.14M | -197.34M | -199.28M | -202.01M | -195.88M | -219.25M | -217.44M | -204.5M | -198.13M | -171.77M | -156.78M | -143.74M | -128.18M | -151.81M | -132.51M | -102.55M | -165.37M | -105.02M | -88.61M | -89.23M |
Selling & General & Admin | 54.39M | 56.47M | 52.35M | 49.91M | 52.8M | 52.29M | 50.16M | 50.94M | 47.34M | 45.39M | 43.39M | 39.93M | 36.04M | 32.75M | 29.82M | 27.38M | 23.8M | 17.59M | 12.76M | 6.91M | 3.89M | 2.73M |
Research & Development | 146.2M | 154.18M | 160.64M | 160.03M | 156.38M | 158.08M | 155.29M | 162.64M | 163.27M | 154.8M | 147.91M | 135.51M | 119.59M | 103.93M | 86.73M | 110.55M | 92.91M | 79.66M | 70.55M | 18.92M | 11.52M | 5.83M |
Other Expenses | -45.85M | -47.71M | -45.85M | -45.85M | -1.86M | n/a | -1.32M | 12.19M | 12.18M | 12.18M | 13.5M | -1K | n/a | n/a | n/a | n/a | n/a | n/a | -4.57M | -5.83M | -5.83M | -5.83M |
Operating Expenses | 154.75M | 162.94M | 167.13M | 164.09M | 207.32M | 210.36M | 204.14M | 225.77M | 222.79M | 212.38M | 204.79M | 175.44M | 155.63M | 136.68M | 116.54M | 137.93M | 116.71M | 97.26M | 78.75M | 20.01M | 9.58M | 2.73M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 200.59M | 210.65M | 212.98M | 209.94M | 209.18M | 210.36M | 205.45M | 227.09M | 224.11M | 213.69M | 204.79M | 175.44M | 155.63M | 136.68M | 116.54M | 137.93M | 116.71M | 98.42M | 84.47M | 27M | 16.57M | 8.55M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -134K | n/a | n/a | -108K | 57K | -279K | -465K | -145K | -618K | -948K | 619K | -1.96M | -403K | -486K | n/a | 2.37M | 1.25M |
Shares Outstanding (Basic) | 177.22M | 177.1M | 148.76M | 160.5M | 129.19M | 130.88M | 118.6M | 119.76M | 119.19M | 104.47M | 97.38M | 91.85M | 90.47M | 89.06M | 97.21M | 97.21M | 95.73M | 95.73M | 95.73M | 95.73M | 95.73M | 95.73M |
Shares Outstanding (Diluted) | 177.22M | 177.1M | 148.76M | 160.5M | 129.19M | 130.88M | 118.6M | 119.76M | 119.19M | 104.47M | 97.38M | 91.85M | 90.47M | 89.06M | 97.21M | 97.21M | 95.73M | 95.73M | 95.73M | 95.73M | 95.73M | 95.73M |
EPS (Basic) | -1.10 | -1.27 | -1.38 | -1.48 | -1.60 | -1.66 | -1.70 | -2.01 | -2.13 | -2.13 | -2.14 | -1.88 | -1.70 | -1.60 | -1.47 | -1.78 | -1.65 | -1.32 | -1.92 | -1.23 | -1 | -0.95 |
EPS (Diluted) | -1.10 | -1.27 | -1.38 | -1.48 | -1.60 | -1.66 | -1.70 | -2.01 | -2.13 | -2.13 | -2.14 | -1.88 | -1.70 | -1.60 | -1.47 | -1.78 | -1.65 | -1.32 | -1.92 | -1.23 | -1 | -0.95 |
EBITDA | -180.49M | -190.9M | -193.82M | -190.18M | -192.44M | -195.63M | -189.75M | -202.49M | -201.76M | -189.07M | -183.3M | -168.61M | -146.89M | -135.01M | -120.55M | -143.25M | -133.36M | -101.1M | -82.93M | -24.2M | -5.58M | -8.48M |
EBIT | -187.89M | -198.37M | -201.14M | -197.34M | -199.28M | -202.15M | -195.88M | -208.15M | -207.09M | -193.98M | -187.96M | -172.88M | -150.56M | -138M | -122.77M | -144.83M | -134.47M | -102.95M | -84.53M | -25.6M | -6.82M | -8.55M |
Depreciation & Amortization | 7.4M | 7.48M | 7.32M | 7.16M | 6.84M | 6.51M | 6.13M | 5.66M | 5.34M | 4.92M | 4.65M | 4.28M | 3.67M | 2.98M | 2.22M | 1.58M | 1.12M | 1.85M | 1.61M | 1.4M | 1.24M | 73K |
Add to Watchlist
Select watchlists to add or remove PRME